Splicing inhibition decreases phosphorylation level of Ser2 in Pol II CTD

Nucleic Acids Research

Volumn 43, Issue 17, 2015, Pages 8258-8267

  Koga, Mitsunori ^a   Hayashi, Megumi ^a   Kaida, Daisuke ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RNA POLYMERASE II; SERINE; ANTISENSE OLIGONUCLEOTIDE; CHROMATIN; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PYRAN DERIVATIVE; SMALL NUCLEAR RNA; SPIRO COMPOUND; SPLICEOSTATIN A;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FRACTIONATION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE STRUCTURE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; UPREGULATION; ANTAGONISTS AND INHIBITORS; CHEMISTRY; CHROMATIN; DRUG EFFECTS; HELA CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; RNA SPLICING;

CHROMATIN; DOWN-REGULATION; HELA CELLS; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN STRUCTURE, TERTIARY; PYRANS; RNA POLYMERASE II; RNA SPLICING; RNA, SMALL NUCLEAR; SERINE; SPIRO COMPOUNDS;

EID: 84949009421     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv740     Document Type: Article

References (54)

1. Hsin, J.P. and Manley, J.L. (2012) The RNA polymerase II CTD coordinates transcription and RNA processing. Genes Dev., 26, 2119-2137.
2. Vannini, A. and Cramer, P. (2012) Conservation between the RNA polymerase I, II, and III transcription initiation machineries. Mol. Cell, 45, 439-446.
3. Buratowski, S. (2009) Progression through the RNA polymerase II CTD cycle. Mol. Cell, 36, 541-546.
4. Drogat, J. and Hermand, D. (2012) Gene-specific requirement of RNA polymerase II CTD phosphorylation. Mol. Microbiol., 84, 995-1004.
5. Egloff, S., Dienstbier, M. and Murphy, S. (2012) Updating the RNA polymerase CTD code: adding gene-specific layers. Trends Genet., 28, 333-341.
6. Zhou, Q., Li, T. and Price, D.H. (2012) RNA polymerase II elongation control. Annu. Rev. Biochem., 81, 119-143.
7. Bartkowiak, B., Liu, P., Phatnani, H.P., Fuda, N.J., Cooper, J.J., Price, D.H., Adelman, K., Lis, J.T. and Greenleaf, A.L. (2010) CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev., 24, 2303-2316.
8. Blazek, D., Kohoutek, J., Bartholomeeusen, K., Johansen, E., Hulinkova, P., Luo, Z., Cimermancic, P., Ule, J. and Peterlin, B.M. (2011) The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev., 25, 2158-2172.
9. Hengartner, C.J., Myer, V.E., Liao, S.M., Wilson, C.J., Koh, S.S. and Young, R.A. (1998) Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol. Cell, 2, 43-53.
10. Komarnitsky, P., Cho, E.J. and Buratowski, S. (2000) Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev., 14, 2452-2460.
11. Ni, Z., Schwartz, B.E., Werner, J., Suarez, J.R. and Lis, J.T. (2004) Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes. Mol. Cell, 13, 55-65.
12. Shim, E.Y., Walker, A.K., Shi, Y. and Blackwell, T.K. (2002) CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. Genes Dev., 16, 2135-2146.
13. Sims, R.J. 3rd, Belotserkovskaya, R. and Reinberg, D. (2004) Elongation by RNA polymerase II: the short and long of it. Genes Dev., 18, 2437-2468.
14. Heidemann, M., Hintermair, C., Voss, K. and Eick, D. (2013) Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription. Biochim. Biophys. Acta, 1829, 55-62.
15. Ahn, S.H., Kim, M. and Buratowski, S. (2004) Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing. Mol. Cell, 13, 67-76.
16. Davidson, L., Muniz, L. and West, S. (2014) 3' end formation of pre-mRNA and phosphorylation of Ser2 on the RNA polymerase II CTD are reciprocally coupled in human cells. Genes Dev., 28, 342-356.
17. Hirose, Y. and Ohkuma, Y. (2007) Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression. J. Biochem., 141, 601-608.
18. Hirose, Y., Tacke, R. and Manley, J.L. (1999) Phosphorylated RNA polymerase II stimulates pre-mRNA splicing. Genes Dev., 13, 1234-1239.
19. Ho, C.K. and Shuman, S. (1999) Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. Mol. Cell, 3, 405-411.
20. McCracken, S., Fong, N., Rosonina, E., Yankulov, K., Brothers, G., Siderovski, D., Hessel, A., Foster, S., Shuman, S. and Bentley, D.L. (1997) 5'-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev., 11, 3306-3318.
21. Mortillaro, M.J., Blencowe, B.J., Wei, X., Nakayasu, H., Du, L., Warren, S.L., Sharp, P.A. and Berezney, R. (1996) A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc. Natl. Acad. Sci. U.S.A., 93, 8253-8257.
22. Gu, B., Eick, D. and Bensaude, O. (2013) CTD serine-2 plays a critical role in splicing and termination factor recruitment to RNA polymerase II in vivo. Nucleic Acids Res., 41, 1591-1603.
23. Ji, X., Zhou, Y., Pandit, S., Huang, J., Li, H., Lin, C.Y., Xiao, R., Burge, C.B. and Fu, X.D. (2013) SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase. Cell, 153, 855-868.
24. Lin, S., Coutinho-Mansfield, G., Wang, D., Pandit, S. and Fu, X.D. (2008) The splicing factor SC35 has an active role in transcriptional elongation. Nat. Struct. Mol. Biol., 15, 819-826.
25. Kramer, A. (1996) The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem., 65, 367-409.
26. Wahl, M.C., Will, C.L. and Luhrmann, R. (2009) The spliceosome: design principles of a dynamic RNP machine. Cell, 136, 701-718.
27. Will, C.L. and Luhrmann, R. (2011) Spliceosome structure and function. Cold Spring Harb. Perspect. Biol., 3, a003707.
28. Kaida, D., Motoyoshi, H., Tashiro, E., Nojima, T., Hagiwara, M., Ishigami, K., Watanabe, H., Kitahara, T., Yoshida, T., Nakajima, H. et al. (2007) Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat. Chem. Biol., 3, 576-583.
29. Kaida, D., Schneider-Poetsch, T. and Yoshida, M. (2012) Splicing in oncogenesis and tumor suppression. Cancer Sci., 103, 1611-1616.
30. Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M. and Mizui, Y. (2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat. Chem. Biol., 3, 570-575.
31. Schneider-Poetsch, T., Usui, T., Kaida, D. and Yoshida, M. (2010) Garbled messages and corrupted translations. Nat. Chem. Biol., 6, 189-198.
32. Yokoi, A., Kotake, Y., Takahashi, K., Kadowaki, T., Matsumoto, Y., Minoshima, Y., Sugi, N.H., Sagane, K., Hamaguchi, M., Iwata, M. et al. (2011) Biological validation that SF3b is a target of the antitumor macrolide pladienolide. FEBS J., 278, 4870-4880.
33. Davidson, L. and West, S. (2013) Splicing-coupled 3' end formation requires a terminal splice acceptor site, but not intron excision. Nucleic Acids Res., 41, 7101-7114.
34. Kaida, D., Berg, M.G., Younis, I., Kasim, M., Singh, L.N., Wan, L. and Dreyfuss, G. (2010) U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature, 468, 664-668.
35. Matter, N. and Konig, H. (2005) Targeted 'knockdown' of spliceosome function in mammalian cells. Nucleic Acids Res., 33, e41.
36. Younis, I., Dittmar, K., Wang, W., Foley, S.W., Berg, M.G., Hu, K.Y., Wei, Z., Wan, L. and Dreyfuss, G. (2013) Minor introns are embedded molecular switches regulated by highly unstable U6atac snRNA. Elife, 2, e00780.
37. Morris, D.P., Lee, J.M., Sterner, D.E., Brickey, W.J. and Greenleaf, A.L. (1997) Assaying CTD kinases in vitro and phosphorylation-modulated properties of RNA polymerase II in vivo. Methods, 12, 264-275.
38. Ma, Y., Chen, L., Wright, G.M., Pillai, S.R., Chellappan, S.P. and Cress, W.D. (2010) CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner. J. Biol. Chem., 285, 9813-9822.
39. Mendez, J. and Stillman, B. (2000) Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol., 20, 8602-8612.
40. Koga, M., Satoh, T., Takasaki, I., Kawamura, Y., Yoshida, M. and Kaida, D. (2014) U2 snRNP is required for expression of the 3' end of genes. PLoS One, 9, e98015.
41. Bensaude, O. (2011) Inhibiting eukaryotic transcription:Which compound to choose? How to evaluate its activity? Transcription, 2, 103-108.
42. Bres, V., Yoh, S.M. and Jones, K.A. (2008) The multi-tasking P-TEFb complex. Curr. Opin. Cell Biol., 20, 334-340.
43. Marshall, N.F. and Price, D.H. (1995) Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem., 270, 12335-12338.
44. Yamaguchi, Y., Shibata, H. and Handa, H. (2013) Transcription elongation factors DSIF and NELF: promoter-proximal pausing and beyond. Biochim. Biophys. Acta, 1829, 98-104.
45. Cho, E.J., Kobor, M.S., Kim, M., Greenblatt, J. and Buratowski, S. (2001) Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev., 15, 3319-3329.
46. Martins, S.B., Rino, J., Carvalho, T., Carvalho, C., Yoshida, M., Klose, J.M., de Almeida, S.F. and Carmo-Fonseca, M. (2011) Spliceosome assembly is coupled to RNA polymerase II dynamics at the 3' end of human genes. Nat. Struct. Mol. Biol., 18, 1115-1123.
47. Furumai, R., Uchida, K., Komi, Y., Yoneyama, M., Ishigami, K., Watanabe, H., Kojima, S. and Yoshida, M. (2010) Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF. Cancer Sci., 101, 2483-2489.
48. Chathoth, K.T., Barrass, J.D., Webb, S. and Beggs, J.D. (2014) A splicing-dependent transcriptional checkpoint associated with prespliceosome formation. Mol. Cell, 53, 779-790.
49. Bondarenko, V.A., Steele, L.M., Ujvari, A., Gaykalova, D.A., Kulaeva, O.I., Polikanov, Y.S., Luse, D.S. and Studitsky, V.M. (2006) Nucleosomes can form a polar barrier to transcript elongation by RNA polymerase II. Mol. Cell, 24, 469-479.
50. Kireeva, M.L., Hancock, B., Cremona, G.H., Walter, W., Studitsky, V.M. and Kashlev, M. (2005) Nature of the nucleosomal barrier to RNA polymerase II. Mol. Cell, 18, 97-108.
51. Li, B., Carey, M. and Workman, J.L. (2007) The role of chromatin during transcription. Cell, 128, 707-719.
52. Gowher, H., Brick, K., Camerini-Otero, R.D. and Felsenfeld, G. (2012) Vezf1 protein binding sites genome-wide are associated with pausing of elongating RNA polymerase II. Proc. Natl. Acad. Sci. U.S.A., 109, 2370-2375.
53. Gromak, N., West, S. and Proudfoot, N.J. (2006) Pause sites promote transcriptional termination of mammalian RNA polymerase II. Mol. Cell. Biol., 26, 3986-3996.
54. Robson-Dixon, N.D. and Garcia-Blanco, M.A. (2004) MAZ elements alter transcription elongation and silencing of the fibroblast growth factor receptor 2 exon IIIb. J. Biol. Chem., 279, 29075-29084.